Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, cilt.11, sa.4, ss.288-292, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 11 Sayı: 4
- Basım Tarihi: 2015
- Doi Numarası: 10.1111/ajco.12358
- Dergi Adı: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.288-292
- Anahtar Kelimeler: metastatic renal cell carcinoma, platelet to lymphocyte ratio, prognosis, CARCINOMA, SURVIVAL, INFLAMMATION, SORAFENIB
- Akdeniz Üniversitesi Adresli: Evet
Özet
AimThe objective of this study was to evaluate the blood platelet-lymphocyte ratio (PLR) for its prognostic value in patients with metastatic renal cell cancer (RCC).